fashion -WSS

fashion

author：explore 2025-09-30 14:10:15 - browse：3

Representative fluorescent multiplex immunohistochemistry colorful staining of healthy human colon. -- cancer coverage from STAT — Staining reveals different immune cells in a healthy human colon. Courtesy Olivia Newton-John Cancer Research institute

Within the linings of our guts, immune cells patrol like sentries on a castle wall. These cells, called intraepithelial T lymphocytes, are constantly probing the cells of the gut barrier for signs of disease, killing any cells that appear suspect due to infections or cancer mutations.

A new paper published in Science Immunologyon Friday suggests that a subtype of T cells called gamma-delta T cells may be key to that process — and that a protein known as TCF-1 is central to controlling their actions. The work, led by Australian researchers, helps unlock the long underappreciated role of these cells in cancer defense and could open new directions for developing immunotherapies for colorectal cancer, immunologists said.

Gamma-delta T cells have been “largely understudied” compared to their immune counterparts, alpha-beta T cells, said Ana Carrizosa Anderson, a cancer researcher at Harvard University who did not work on the study. “This study certainly helps cement the role of gamma-delta T cells in colon malignancy,” she said. “I think it provides a foundation for building understanding of some basic biology or some therapeutic approaches.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Amid AI frenzy, a top HHS official's quest to create safeguards

WSS

As AI in medicine takes off, can 'human in the loop' prevent harm?

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

As AI in medicine takes off, can 'human in the loop' prevent harm?

Why patients can’t get everything they want on drug pricing

What causes rare myocarditis in young men after Covid vaccines?

Pushing for an NIH office for post

focus

fashion

focus

The high cost of giving birth even with insurance

What it's like to live with paralysis for one psychologist

Bright Health sells Medicare Advantage business to Molina

Steward Health Care Massachusetts hospitals face fiscal disaster

Medical records are filled with copy

Steward Health Care Massachusetts hospitals face fiscal disaster

New air purifier tech could be key to improving indoor air quality

What to watch for from Zogenix and Amicus clinical trials

What does generative AI mean for health care? We asked experts

Will the FTC rein in IQVIA's health data empire?

focus

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

CDC Director Mandy Cohen on transparency, trust, and health

UCLA team creates talking throat patch for voice disorders

Roche’s Alnylam deal shows drug firms interested in heart drugs

FDA advisers back CAR

focus

focus

hotspot

focus